• Universe Pharmaceuticals adopted 2026 Equity Incentive Plan on April 14, 2026.
• Plan authorizes up to 84,500 ordinary shares for awards.
• Share pool will increase each January starting in 2027 by 10% of issued and outstanding ordinary shares, subject to a lower board-set amount.
• Plan caps awards for any director or officer if resulting ownership would exceed 75% of total combined voting power.
• Options granted under plan cannot run longer than 10 years from grant date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Universe Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-044641), on April 16, 2026, and is solely responsible for the information contained therein.